Search Results

LOOKING INTO THE GENETICS OF INHERITED RETINAL DISEASES WITH DR. ROB KOENEKOOP

Meet the Expert: Dr. Robert Koenekoop is a Montreal-based clinician-scientist, meaning he is both a medical doctor, trained in Ophthalmology and also does research about inherited retinal diseases (IRDs). He’s also a...

11 YEARS IN THE MAKING: SUPREME COURT OF CANADA UPHOLDS GENETIC NON-DISCRIMINATION ACT (GNDA)

In the past decades, genetic testing has played a growing role in the diagnosis of inherited eye diseases such as retinitis pigmentosa, Usher syndrome and Leber Congenital Amaurosis. Not only can a...

HOW FBC’S HEALTH INFORMATION LINE SUPPORTS YOU: Q&A WITH HEALTH INFORMATION OFFICER SHARI SHAW

Vision health information can be hard to navigate. Whether you or someone you know has been newly diagnosed with an eye disease, or have been living with an eye disease and are...

RESEARCH NEWS

October 2025 Could eye drops or vaccines slow vision loss? Recent studies have uncovered two exciting paths toward developing gentler treatments for eye disease. In the first study, scientists created eye drops...

IMPROVING AMD TREATMENTS BY STUDYING CELL MOVEMENT

Age-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 50, affecting approximately 1.4 million Canadians. There are two kinds of AMD: dry AMD which...

BIOLOGICAL MECHANISMS DRIVING HDAC INHIBITOR TREATMENT EFFECTS IN RP

Valproic acid (VA), belongs to a family of drugs called HDAC inhibitors (HDACi) and has been tested as a potential treatment for retinitis pigmentosa (RP) with mixed results. In some clinical trials,...